Tranexamic acid
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tranexamic acid and local guidelines before prescribing.
Mechanism
Antifibrinolytic blocking lysine binding sites on plasminogen.
Uses
Haemorrhage in trauma, menorrhagia, post-partum haemorrhage, surgical bleeding.
Dosing
- Tranexamic acid - IV (e.g. 1 g) or nebulised.
Respiratory: Emergencies - Tranexamic acid Haemoptysis | e.g. 1 g IV, or nebulised.
Respiratory: Emergencies - Tranexamic acid 1 g IV over 10 minutes (then 1 g over 8 hours) - in trauma within 3 hours and obstetric haemorrhage. Not in GI bleeding (no benefit, more clots).
Haematology: Emergencies - Tranexamic acid 1 g IV over 10 min, then 1 g over 8 h | Trauma (within 3 hours), obstetric haemorrhage, surgery; not GI bleeding.
Haematology: Emergencies
4 more dose entries from the chapters
- Tranexamic acid for surgery with expected blood loss over 500 mL.
Haematology: Haemoglobinopathies and Transfusion - Tranexamic acid 1 g IV | Surgery with expected blood loss over 500 mL; major bleeding.
Haematology: Haemoglobinopathies and Transfusion - Tranexamic acid | Antifibrinolytic — PPH (1 g IV within 3 hours — WOMAN trial) | Seizures at high doses; caution with VTE history
Obstetrics - Tranexamic acid 1 g IV; oxytocin infusion; misoprostol .
Obstetrics
Side effects
Nausea, diarrhoea, seizures at high doses, thrombotic events.
Interactions
Combined oral contraceptives increase thrombosis risk.
Contraindications and cautions
Active thromboembolism, subarachnoid haemorrhage
Monitoring
Seizures, renal function
Pregnancy and breastfeeding
Acceptable
Renal and hepatic impairment
Reduce dose in renal impairment
Overdose and reversal
Supportive
Special advice
Early administration is critical in trauma; reduce in renal impairment; avoid in active thromboembolic disease.
More from the textbook: uses, cautions and other points
- Massive haemoptysis | Bleeding side down; oxygen; tranexamic acid; reverse anticoagulation; anaesthetics and interventional radiology
Respiratory: Emergencies - Large-bore access, crossmatch, reverse any anticoagulation; tranexamic acid.
Respiratory: Emergencies - Haemoptysis - palliative radiotherapy, tranexamic acid, bronchial artery embolisation.
Respiratory: Lung Cancer - Tranexamic acid | Haemoptysis (oral or nebulised).
Respiratory: Lung Cancer - Tranexamic acid is not recommended - the HALT-IT trial showed no benefit and more VTE.
Gastroenterology: Gastroenterology Emergencies (Complete) - Upper GI bleed: resuscitate, Blatchford score (0–1 can go home), restrictive transfusion, endoscopy within 24 hours, no PPI before endoscopy, no tranexamic acid.
Gastroenterology: Gastroenterology Emergencies (Complete)
Where it is discussed in the book
- Respiratory: Emergencies (4 mentions)
- Respiratory: Lung Cancer (2 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (7 mentions)
- Haematology: History and Examination (1 mention)
- Haematology: Emergencies (4 mentions)
- Haematology: Haemoglobinopathies and Transfusion (2 mentions)
- Haematology: Haemostasis and Thrombosis (5 mentions)
- Oncology: Emergencies (1 mention)
- Palliative: Symptoms Management (3 mentions)
- Obstetrics (4 mentions)
- Obstetrics: Obstetrics: Emergencies (5 mentions)
- Gynaecology: Menstrual Disorders (6 mentions)
- ENT Anatomy Physiology (1 mention)
- ENT: Emergencies (5 mentions)
- Surgery: Surgical principles and perioperative care (1 mention)
- Surgery: Major trauma and burns (6 mentions)
- Emergency Medicine: Triage, systems, prehospital care and major incidents (2 mentions)
- Acute Medicine: The deteriorating patient (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Clinical imaging: Musculoskeletal and trauma imaging (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Clinical Genetics: Single-gene, repeat-expansion and mitochondrial disorders (2 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (1 mention)